Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 315

    Singh brothers resign from board of Religare Enterprises

    Singh brothers resign from board of Religare Enterprises

    Ruby Khatun Khatun15 Feb 2018 10:45 AM IST
    New Delhi: Diversified financial services firm Religare Enterprises said Malvinder Mohan Singh and Shivinder Mohan Singh have resigned from the...
    Calcutta HC sets aside Centers decision for strategic sale of Bengal Chemicals

    Calcutta HC sets aside Center's decision for strategic sale of Bengal Chemicals

    Ruby Khatun Khatun15 Feb 2018 10:30 AM IST
    Kolkata: The Calcutta High Court has set aside the Centres decision to go for strategic sale of century-old Bengal Chemicals and Pharmaceuticals Ltd...
    Aster DM Healthcare IPO subscribed 45 percent on day 2

    Aster DM Healthcare IPO subscribed 45 percent on day 2

    Ruby Khatun Khatun15 Feb 2018 10:15 AM IST
    New Delhi: The initial public offer of Aster DM Healthcare has subscribed 45 percent on the second day of its public issue, according to merchant...
    Eli Lilly appoints Luca Visini as MD of India operations

    Eli Lilly appoints Luca Visini as MD of India operations

    Medical Dialogues Bureau15 Feb 2018 10:00 AM IST
    New Delhi: US pharma major Eli Lilly and Company said it has appointed Luca Visini as managing director of its Indian subsidiary with effect from...
    FDA approves Johnson and Johnson prostate cancer treatment

    FDA approves Johnson and Johnson prostate cancer treatment

    Ruby Khatun Khatun15 Feb 2018 9:45 AM IST
    The U.S. Food and Drug Administration approved Johnson and Johnson’s Erleada for use in prostate cancer patients whose disease has not spread but...
    Bristol-Myers to pay 1.85 billion dollars in cancer deal with Nektar

    Bristol-Myers to pay 1.85 billion dollars in cancer deal with Nektar

    Ruby Khatun Khatun15 Feb 2018 9:30 AM IST
    Bristol-Myers Squibb Co will pay Nektar Therapeutics $1.85 billion for a global development and profit-sharing deal on a promising Nektar cancer drug,...
    Fortis inks pact to acquire portfolio of RHT Health Trust

    Fortis inks pact to acquire portfolio of RHT Health Trust

    Medical Dialogues Bureau14 Feb 2018 7:14 PM IST
    New Delhi: Fortis Healthcare today said it has entered into definitive agreements with Singh Brothers- promoted RHT Health Trust (RHT) to acquire an...
    GSK Consumer Healthcare Q3 profit up 20 pc at Rs 163.66 cr

    GSK Consumer Healthcare Q3 profit up 20 pc at Rs 163.66 cr

    Medical Dialogues Bureau14 Feb 2018 7:14 PM IST
    New Delhi: GlaxoSmithKline (GSK) Consumer Healthcare Ltd today reported a 19.97 percent increase in its standalone net profit at Rs 163.66 crore for...
    Diabetic drugs : Cipla partners with Novartis and Johnson while Alkem partners Dong A

    Diabetic drugs : Cipla partners with Novartis and Johnson while Alkem partners Dong A

    Ruby Khatun Khatun14 Feb 2018 1:26 PM IST
    MUMBAI: In order to foray into antidiabetic drug market pharma giant Cipla and Mumbai based Alkem Pharma has tied up with multinationals for gliptin...
    Fortis board accepts resignations of Singh brothers

    Fortis board accepts resignations of Singh brothers

    Medical Dialogues Bureau14 Feb 2018 1:25 PM IST
    Fortis Healthcare today said its board has accepted the resignations of promoters Malvinder Mohan Singh and Shivinder Mohan Singh.The board of...
    Local stent makers welcome NPPA price ceiling

    Local stent makers welcome NPPA price ceiling

    Medical Dialogues Bureau14 Feb 2018 1:24 PM IST
    New Delhi: The government' decision to revise ceiling prices of bare metal stents and drug-eluting ones has evoked mixed reactions from the medical...
    Lupin launches generic influenza treatment capsules in the US

    Lupin launches generic influenza treatment capsules in the US

    Medical Dialogues Bureau13 Feb 2018 11:00 AM IST
    New Delhi: Drug firm Lupin said it has launched in the US market its generic Oseltamivir Phosphate capsules, used for the treatment of influenza.The...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Laurus Labs gets 2 USFDA observations for Visakhapatnam facility

    Laurus Labs gets 2 USFDA observations for Visakhapatnam facility

    After giving exemption, NPPA asks Meril Life Sciences for MRP of its stent

    After giving exemption, NPPA asks Meril Life Sciences for MRP of its stent

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    FIRST: Mylan, Micro Labs get USFDA nod for generic version of blood thinner Eliquis

    FIRST: Mylan, Micro Labs get USFDA nod for generic version of blood thinner Eliquis

    Philips announces DEFINE GPS global multicenter study to assess outcomes of PCI procedures guided by integrated iFR and interventional X-ray images

    Philips announces DEFINE GPS global multicenter study to assess outcomes of PCI procedures guided by...

    Bharat Biotech join hands with University of Wisconsin, FluGen for COVID-19 vaccine- CoroFlu

    Bharat Biotech join hands with University of Wisconsin, FluGen for COVID-19 vaccine- CoroFlu

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok